VAXinia

N/A

Report date: 2026/03/07 20:00:27

Base Information

Drug NameVAXinia
Drug Alias NameCF-33CF33-hNISCF-33-hNIS
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionCell death stimulantsImmunologic cytotoxicityT lymphocytes stimulants +[4] 
TargetsSodium/iodide cotransporter
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisBile Duct Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesImugene LtdCity Of Hope National Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImugene Ltd
Active IndicationsN/A
Inactive IndicationsSolid tumoursNeoplasm MetastasisBile Duct Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A